Diagnostic Tests for Chest Pressure
For patients presenting with chest pressure, the initial diagnostic workup should include a 12-lead ECG within 10 minutes of first medical contact, focused history, targeted cardiovascular examination, and high-sensitivity troponin measurement to rapidly identify or exclude potentially life-threatening causes. 1
Initial Evaluation
Immediate Tests (First 10 Minutes)
- 12-lead ECG: Must be performed within 10 minutes of first medical contact 2, 1
- Vital signs: Blood pressure, heart rate, respiratory rate, oxygen saturation
- High-sensitivity cardiac troponin (hs-cTn): Initial measurement with follow-up testing based on protocol 2, 1
Focused History Elements
- Pain characteristics: location, radiation, quality, severity, duration
- Aggravating/alleviating factors
- Associated symptoms (diaphoresis, nausea, dyspnea, etc.)
- Cardiovascular risk factors
- Previous cardiac history
Risk Stratification
After initial assessment, patients should be stratified using validated risk scores:
- HEART score (History, ECG, Age, Risk factors, Troponin)
- TIMI risk score (Thrombolysis In Myocardial Infarction)
- GRACE risk score (Global Registry of Acute Coronary Events) 1
Diagnostic Algorithm Based on Risk Level
High-Risk Features
- ST-segment elevation or new LBBB
- Hemodynamic instability
- Ongoing chest pain
- Positive cardiac biomarkers
- High-risk score on risk stratification tools
- ECG changes concerning for ischemia
- Signs of heart failure 1
Recommended Tests for High-Risk Patients:
- Immediate cardiology consultation
- Coronary angiography if ST-elevation MI or high-risk ACS
- Transthoracic echocardiography to evaluate ventricular and valvular function, detect wall motion abnormalities, and identify pericardial effusion 2, 1
- CT angiography if aortic dissection is suspected 2
- Serial troponin measurements (if initial is negative)
Intermediate-Risk Features
- Atypical symptoms but concerning risk factors
- Non-diagnostic ECG changes
- Negative initial troponin but symptoms <6 hours from onset
- Intermediate risk score on stratification tools 1
Recommended Tests for Intermediate-Risk Patients:
- Serial ECGs and troponins (0h/1h algorithm with additional measurement at 3h if inconclusive) 1
- Chest X-ray to exclude pulmonary causes 2
- Transthoracic echocardiography - especially valuable in patients with known underlying cardiac disease (valvular, pericardial, or primary myocardial disease) 2
- Non-invasive cardiac testing before discharge:
Low-Risk Features
- Non-cardiac chest pain characteristics
- Normal ECG
- Negative serial troponins
- Low risk score on stratification tools
- Alternative diagnosis established
- Resolution of symptoms 1
Recommended Tests for Low-Risk Patients:
- No urgent diagnostic testing is needed for patients determined to be low risk 2, 1
- Consider outpatient follow-up with primary care provider
Special Considerations for Specific Conditions
Suspected Aortic Dissection
- CT angiography is the initial imaging modality of choice 2
- Transoesophageal echocardiography may be considered if CT is not available or in unstable patients 2
Suspected Pulmonary Embolism
- CT pulmonary angiography (CTPA) is the primary imaging modality 2
- D-dimer testing (negative result can exclude PE in low/intermediate probability patients) 2
- V/Q scan if CTPA is contraindicated 2
Suspected Pericardial Disease
- Transthoracic echocardiography to evaluate for effusion, constriction, or effusive-constrictive process 2
Common Pitfalls to Avoid
- Delayed ECG acquisition - must be obtained within 10 minutes of first medical contact
- Premature discharge - 2-5% of ACS patients are inappropriately discharged from the ED 3
- Overreliance on troponin - normal troponin doesn't exclude ACS in early presenters
- Missing atypical presentations - especially in women, elderly, and diabetic patients
- Failure to consider non-cardiac causes - such as pulmonary embolism, aortic dissection, or pneumothorax
By following this systematic approach to diagnostic testing for chest pressure, clinicians can efficiently identify life-threatening conditions while avoiding unnecessary testing in low-risk patients.